Microbial proteins, nucleic acids, and membrane lipids

Microbial proteins, nucleic acids, and membrane lipids represent the fundamental molecular building blocks required for the survival, replication, and pathogenesis of bacteria, viruses, and fungi (NIH: Antimicrobial Resistance, 2022). Proteins act as the primary catalysts for metabolic processes and provide structural support, while nucleic acids (DNA and RNA) store and transmit the genetic instructions necessary for life. Membrane lipids form the essential semi-permeable barriers that maintain cellular integrity and regulate the transport of ions and nutrients (Nature Reviews Microbiology, 2017). Most antimicrobial drugs exert their effects by selectively binding to and inhibiting these components; for instance, aminoglycosides target the 30S ribosomal subunit to block protein synthesis, fluoroquinolones inhibit DNA gyrase to prevent nucleic acid replication, and lipopeptides like daptomycin insert into the bacterial membrane to cause depolarization (StatPearls: Antibiotics, 2023). Because this category aggregates multiple distinct classes of macromolecules, it serves as a broad conceptual framework for antimicrobial action rather than a single specific drug target. Effective therapeutic use requires balancing the destruction of these microbial components with the preservation of host cellular structures to avoid systemic toxicity (Nature Reviews Microbiology, 2017).

Other names

Microbial macromoleculesPathogen cellular componentsMicrobial cellular targets

Inhibition of protein synthesis, inhibition of nucleic acid synthesis, and disruption of cell membrane integrity (StatPearls: Antibiotics, 2023).